Halo Collective Inc (HCANF)
0.0001
0.00 (0.00%)
USD |
OTCM |
Jun 20, 16:00
Halo Collective Free Cash Flow: -4.181M for June 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2023 | -4.181M |
| March 31, 2023 | -6.278M |
| December 31, 2022 | -13.89M |
| September 30, 2022 | -21.26M |
| June 30, 2022 | -31.73M |
| March 31, 2022 | -38.69M |
| December 31, 2021 | -38.42M |
| September 30, 2021 | -39.59M |
| June 30, 2021 | -29.37M |
| March 31, 2021 | -21.10M |
| December 31, 2020 | -13.62M |
| September 30, 2020 | -6.880M |
| June 30, 2020 | -9.979M |
| March 31, 2020 | -16.80M |
| December 31, 2019 | -16.76M |
| September 30, 2019 | -13.71M |
| June 30, 2019 | -10.75M |
| March 31, 2019 | -2.720M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -0.3918M |
| March 31, 2018 | -0.2888M |
| December 31, 2017 | -0.2196M |
| September 30, 2017 | -0.2111M |
| June 30, 2017 | -0.2234M |
| Date | Value |
|---|---|
| March 31, 2017 | -0.1985M |
| December 31, 2016 | -0.2555M |
| September 30, 2016 | -0.224M |
| June 30, 2016 | -0.2289M |
| March 31, 2016 | 0.0448M |
| December 31, 2015 | 0.0596M |
| September 30, 2015 | -0.2089M |
| June 30, 2015 | -0.3848M |
| March 31, 2015 | -0.3315M |
| December 31, 2014 | -0.4084M |
| September 30, 2014 | -1.504M |
| June 30, 2014 | -0.4598M |
| March 31, 2014 | 0.2505M |
| December 31, 2013 | -0.6678M |
| September 30, 2013 | -0.9134M |
| June 30, 2013 | -2.758M |
| March 31, 2013 | -6.713M |
| December 31, 2012 | -6.792M |
| September 30, 2012 | -6.474M |
| June 30, 2012 | -5.500M |
| March 31, 2012 | -10.53M |
| December 31, 2011 | -11.04M |
| September 30, 2011 | -10.01M |
| June 30, 2011 | -10.05M |
| March 31, 2011 | -0.7211M |
Free Cash Flow Range, Past 5 Years
-39.59M
Minimum
Sep 2021
-4.181M
Maximum
Jun 2023
-19.59M
Average
-16.76M
Median
Dec 2019
Free Cash Flow Benchmarks
| CEN Biotech Inc | -0.2248M |
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -34.18M |
| Edesa Biotech Inc | -6.340M |
| Lexaria Bioscience Corp | -5.408M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.4658M |
| Cash from Investing (Quarterly) | 0.4945M |
| Cash from Financing (Quarterly) | -0.4607M |
| Free Cash Flow Per Share (Quarterly) | -0.0031 |
| Free Cash Flow to Equity (Quarterly) | -0.8621M |
| Free Cash Flow to Firm (Quarterly) | -0.2378M |